162
Views
1
CrossRef citations to date
0
Altmetric
Cardiovascular Medicine

Empirical anti-tuberculous therapy for the massive pericardial effusion of unknown etiology

, , , , , , , , , , , , & show all
Pages 1507-1513 | Received 04 Apr 2021, Accepted 07 Jun 2021, Published online: 10 Jul 2021

References

  • Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLOS Med. 2016;13(10):e1002152.
  • Global tuberculosis report 2020. Available from: https://www.who.int/tb/publications/global_report/en/
  • Huang J, Shen M, Sun Y. Epidemiological analysis of extrapulmonary tuberculosis in Shanghai. Zhonghua Jie He He Hu Xi Za Zhi. 2000;23(10):606–608.
  • Fu YY, Li JX, Jiang LN, et al. The investigation of the reported case of Extra-pulmonary tuberculosis by medical institutions in Tianjin during 2011–2013. Chinese J Antituberculosis. 2016;38(2):104–109.
  • Wang DM, Li QF, Zhu M, et al. Analysis of infection and drug-resistance in 6107 cases of extrapulmonary tuberculosis in Chengdu area. Zhonghua Jie He Za Zhi. 2017;40(8):592–595.
  • Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005;112(23):3608–3616.
  • Zhang W, Yan XW, Fu XD, et al. Etiological analysis of the patients with pericardial effusion to be diagnosis (with report of 80 cases). Chinese J Cardiovasc Med. 2001;6(2):89–92.
  • Strang G, Latouf S, Commerford P, et al. Bedside culture to confirm tuberculous pericarditis. Lancet. 1991;338(8782–8783):1600–1601.
  • Mwaba P, Chakaya JM, Petersen E, et al. Advancing new diagnostic tests for latent tuberculosis infection due to multidrug-resistant strains of Mycobacterium tuberculosis – end of the road? Int J Infect Dis. 2020;92S:S69–S71.
  • Mayosi BM, Wiysonge CS, Ntsekhe M, et al. Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) Registry. BMC Infect Dis. 2006;6:2.
  • Adler Y, Charron M, Imazio M, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921–2964.
  • Bian S, Zhang Y, Zhang L, et al. Diagnostic value of interferon-γ release assays on pericardial effusion for diagnosis of tuberculous pericarditis. PLOS One. 2016;11(10):e0165008.
  • Zhang L, Zhang Y, Shi X, et al. Utility of T-cell interferon-γ release assays for diagnosing tuberculous serositis: a prospective study in Beijing, China. PLOS One. 2014;9(1):e85030.
  • Klein AL, Abbara S, Agler DA, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013;26(9):965–1012.e15.
  • Wang FF, Hsu J, Jia FW, et al. Left ventricular strain is associated with acute postoperative refractory hypotension in patients with constrictive pericarditis and preserved ejection fraction. J Thorac Dis. 2018;10(7):4147–4155.
  • Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J. 2013;34(16):1186–1197.
  • Lin X, Xu RY, Liu JZ, et al. Effect of right heart systolic function on outcomes in patients with constrictive pericarditis undergoing pericardiectomy. Chin Med J. 2016;129(2):154–161.
  • Imazio M, Gaido L, Battaglia A, et al. Contemporary management of pericardial effusion: practical aspects for clinical practice. Postgrad Med. 2017;129(2):178–186.
  • Kohli M, Schiller I, Dendukuri N, et al. Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance. Cochrane Database Syst Rev. 2018;8(8):CD012768.
  • Dendukuri N, Schiller I, de Groot J, et al. Concerns about composite reference standards in diagnostic research. BMJ. 2018;360:j5779.
  • Christopher DJ, Schumacher SG, Michael JS, et al. Performance of Xpert MTB/RIF on pleural tissue for the diagnosis of pleural tuberculosis. Eur Respir J.2013;42(5):1427–1429.
  • Nhu NT, Heemskerk D, Thu do DA, et al. Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis. J Clin Microbiol. 2014;52(1):226–233.
  • Tortoli E, Russo C, Piersimoni C, et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J. 2012;40(2):442–447.
  • Denkinger CM, Schumacher SG, Boehme CC, et al. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2014;44(2):435–446.
  • Imazio M, Lazaros G, Valenti A, et al. Outcomes of idiopathic chronic large pericardial effusion. Heart. 2019;105(6):477–481.
  • Imazio M, Demichelis B, Parrini I, et al. Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. J Am Coll Cardiol. 2004;43(6):1042–1046.
  • Wiysonge CS, Ntsekhe M, Thabane L, et al. Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev. 2017;9(9):CD000526.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.